Now has notified Amazon about a brand posting Certificates of Analysis from a third-party testing lab on their website which confirm the fill weight of its products, but not the identity, potency, or purity.
Photo © Shutterstock.com/bixstock
Now (Bloomingdale, IL) has notified Amazon about a brand posting Certificates of Analysis from a third-party testing lab on their website which confirm the fill weight of its products, but not the identity, potency, or purity. Now argues that these kinds of documents are misleading to consumers because they would be unlikely to understand that fill weight has nothing to do with hallmarks of quality such as identity, potency, and purity.
“I think many of us had hoped that Amazon would institute safeguards that would marginalize companies engaging in this type of behavior,” said Dan Richard, Now’s vice president of global sales and marketing, in a press release. “My wish is for Amazon to be very specific in their documentation requirements, be fully transparent with their rules, and enforce them for all brands selling on their platform.”
Now has been testing products from Amazon and reporting the results of these tests to the public as well as the ecommerce giant so that Amazon can take action and also better understand the dietary supplement industry, and how to keep an eye on bad actors. According to Now, after proving the serious quality failings of lesser-known supplement brands on Amazon, the company has instituted stronger requirements on dietary supplement sellers. Consumers are becoming savvier about the products they buy, and Certificates of Analysis help validate that their purchasing decisions are wise. Therefore, tricking consumers with misleading Certificates of Analysis can be a new and insidious way to deceive consumers.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.